Contact Lenses for Vision Correction
JA
Overseen ByJose A Vega, OD,MSc,PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: CooperVision International Limited (CVIL)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
What You Need to Know Before You Apply
What is the purpose of this trial?
The aim of this study is to assess contact lens performance and acceptance.
Who Is on the Research Team?
PK
Pete Kollbaum, OD, PhD
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for individuals with vision issues like farsightedness or near-sightedness. Participants should be interested in trying out different types of contact lenses to assess their performance and comfort.Inclusion Criteria
Refractive error of -6.00 to -0.50DS or +0.50 to +6.00DS and less than or equal to 0.75DC as vertexed to the corneal plane
Anisometropia no greater than 1.50D, based on vertexed manifest refraction spherical equivalent
Can achieve visual acuity of at least 20/25 in each eye with spherical equivalent manifest refraction
See 2 more
Exclusion Criteria
Used gas permeable/hard contact lenses (including orthokeratology) in the previous 3 months
Participation in a contact lens or lens care product trial in the previous 30 days
I am not on any medication that prevents me from wearing contact lenses.
See 1 more
What Are the Treatments Tested in This Trial?
Interventions
- comfilcon A lens
- delefilcon A lens
- fanfilcon A lens
- kalilfilcon A lens
- lehfilcon A lens
- samfilcon A lens
- senofilcon A bi-weekly lens
- senofilcon A daily disposable lens
- senofilcon A with blue light technology lens
- serafilcon A lens
- somofilcon A lens
- stenfilcon A lens
- verofilcon A lens
Trial Overview The study is testing various contact lenses made from materials like stenfilcon A, fanfilcon A, and others. It aims to compare how these lenses perform in terms of vision correction and user acceptance over a set period.
How Is the Trial Designed?
13Treatment groups
Experimental Treatment
Group I: verofilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group II: stenfilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group III: somofilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group IV: serafilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group V: senofilcon A lens with blue light technologyExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group VI: senofilcon A lens daily disposableExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group VII: senofilcon A lens bi-weekly replacementExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group VIII: samfilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group IX: lehfilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group X: kalifilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group XI: fanfilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group XII: delefilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Group XIII: comfilcon A lensExperimental Treatment1 Intervention
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Find a Clinic Near You
Who Is Running the Clinical Trial?
CooperVision International Limited (CVIL)
Lead Sponsor
Trials
171
Recruited
14,600+
Dr. Patrizia Cavazzoni
CooperVision International Limited (CVIL)
Chief Medical Officer
MD from Harvard Medical School
Steven Robins
CooperVision International Limited (CVIL)
President, Americas
Bachelor of Arts from Bates College, participated in Pfizer Global Leadership Program with Harvard University
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.